Welcome to the Inaugural Donor Selection & Cell Source Summit
Unravelling the Secrets of High-Quality Starting Material for Successful Clinical and Commercial Development of Off-the-Shelf Cell Therapies
With the field in eager anticipation for truly positive safety and clinical data of allogeneic cell therapies showcasing long-term persistence and durability – it is clear now more than ever that the field must assess the impact of donor contribution to the final cell product quality, and overcome the scalability challenges associated with having a small ‘super-donor’ pool.
The Donor Selection & Cell Source Summit is your ultimate platform to explore the latest global regulatory requirements and differences on donor testing, understand the novel genome sequencing data being used to inform donor selection, and forge new partnerships to ease logistical coordination with donation sites to ensure exclusive availability of selected donor pools.
Whether your team is ahead of the curve with an established donor screening program and selection criteria, or if you are looking to gain deeper insights into this space to flesh out your future donor recruitment and management strategy - don’t miss out on this industry-defining forum specifically designed to inspire and facilitate the transparent and interactive discussions on how to transform off-the-shelf cell therapies right from the start.
Who Will You Meet?
With cell therapy C-level executives, VPs and Directors across process development, supply chain, manufacturing, analytics and more uniting in San Francisco, this meeting boasts an unmatched opportunity to collaborate with the industry leaders from biopharma, academia, blood banks and more to develop the ultimate strategy for ensuring a high-quality starting material for your allogeneic pipeline.